Elevance Price To Sales Ratio from 2010 to 2024
| ELV Stock | USD 365.96 0.52 0.14% |
Price To Sales Ratio | First Reported 2010-12-31 | Previous Quarter 0.6414556 | Current Value 0.46 | Quarterly Volatility 0.17092324 |
Check Elevance Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Elevance Health's main balance sheet or income statement drivers, such as Interest Expense of 1.1 B, Total Revenue of 179.9 B or Gross Profit of 161.7 B, as well as many indicators such as Price To Sales Ratio of 0.46, Dividend Yield of 0.0153 or PTB Ratio of 1.5. Elevance financial statements analysis is a perfect complement when working with Elevance Health Valuation or Volatility modules.
Elevance | Price To Sales Ratio |
Latest Elevance Health's Price To Sales Ratio Growth Pattern
Below is the plot of the Price To Sales Ratio of Elevance Health over the last few years. Price to Sales Ratio is figured by comparing Elevance Health stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Elevance Health sales, a figure that is much harder to manipulate than other Elevance Health multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. Elevance Health's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Elevance Health's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 0.49 X | 10 Years Trend |
|
Price To Sales Ratio |
| Timeline |
Elevance Price To Sales Ratio Regression Statistics
| Arithmetic Mean | 0.55 | |
| Geometric Mean | 0.53 | |
| Coefficient Of Variation | 31.02 | |
| Mean Deviation | 0.15 | |
| Median | 0.46 | |
| Standard Deviation | 0.17 | |
| Sample Variance | 0.03 | |
| Range | 0.5135 | |
| R-Value | 0.73 | |
| Mean Square Error | 0.01 | |
| R-Squared | 0.53 | |
| Significance | 0 | |
| Slope | 0.03 | |
| Total Sum of Squares | 0.41 |
Elevance Price To Sales Ratio History
About Elevance Health Financial Statements
Elevance Health investors use historical fundamental indicators, such as Elevance Health's Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Elevance Health. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 0.64 | 0.46 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Elevance Stock Analysis
When running Elevance Health's price analysis, check to measure Elevance Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevance Health is operating at the current time. Most of Elevance Health's value examination focuses on studying past and present price action to predict the probability of Elevance Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevance Health's price. Additionally, you may evaluate how the addition of Elevance Health to your portfolios can decrease your overall portfolio volatility.